+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pharmaceutical Analytical Testing Outsourcing Market Size, Share & Trends Analysis Report by Service (Bioanalytical, Stability, Method Development & Validation), by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4764564
  • Report
  • February 2020
  • Region: Global
  • 92 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Boston Analytical
  • Boston Analytical
  • Eurofins Scientific
  • Intertek Group Plc
  • SGS SA
  • Toxikon, Inc.
  • MORE
The global pharmaceutical analytical testing outsourcing market size is expected to reach USD 11.4 billion by 2027, according to this report registering a CAGR of 8.3% over the forecast period. Increasing pipelines for biological candidates, rising demand for additional analytical details on drugs, and process development by regulatory agencies are boosting the market growth.

Analytical testing helps in providing real-time product quality control along with optimizing and monitoring processes, characterizing biosimilars and biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to benefit from skilled and experienced professionals, as well as to access expensive analytical equipment which are not available in-house.

Increased development of biologics is also creating a demand for analytical testing services. In the last three decades, biologics have taken the center stage in the discovery and development of drugs. Moreover, there is a high demand to define higher-order biological structures. The need for better product characterization, along with comparability studies, especially for biosimilars, further leads to drug companies outsourcing these services.

A patent cliff, particularly for small molecules in the pharmaceutical industry leads to a decline in revenue, thereby affecting profits. Over the next few years, several best-selling biologics would come toward the end of patent life, such as Humira. Drug innovators are therefore under constant pressure to bring new products through the pipeline at a faster rate. Developing advanced analytical testing to assess and monitor the quality attributes of these products requires a broader set of equipment and expertise, which is beyond the internal capacity of pharma companies. This would subsequently lead to increased instances of outsourcing pharmaceutical analytical testing services.

Further key findings from the report suggest:
  • The outsourcing of clinical bioanalytical testing services emerged as the largest segment in 2019 with a share of around 79% owing to the increasing number of clinical trials
  • The extractable and leachable services segment is expected to witness a significant growth rate owing to an increasing number of vendors offering these services at competitive prices
  • North America dominated the global market with a share of 54.2% in 2019 as the region is one of the top manufacturing hubs of highly reliable, complex, and high-end pharmaceuticals
  • Some of the players operating in the pharmaceutical analytical testing outsourcing market are Toxikon, Inc., Intertek Group PLC, SGS SA, Eurofins Scientific, Boston Analytical, Pace Analytical Services, LLC, West Pharmaceutical Services, Inc., Intertek Group Plc, Pharmaceutical Product Development, LLC, WuXi AppTec, Inc., and Charles River Laboratories International, Inc.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Boston Analytical
  • Boston Analytical
  • Eurofins Scientific
  • Intertek Group Plc
  • SGS SA
  • Toxikon, Inc.
  • MORE
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. Regional scope
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Pharmaceutical Analytical Testing Outsourcing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Innovation
3.3.1.2. Regulation safety and quality
3.3.1.3. End-users volume
3.3.1.4. Pricing
3.3.2. Market Restraint Analysis
3.3.2.1. Data insecurity
3.3.2.2. Third party performance
3.3.3. Industry Challenges
3.4. Pharmaceutical Analytical Testing Outsourcing: Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier Power
3.4.1.2. Buyer Power
3.4.1.3. Substitution Threat
3.4.1.4. Threat from new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political Landscape
3.4.2.2. Environmental Landscape
3.4.2.3. Social Landscape
3.4.2.4. Technology Landscape
3.4.2.5. Legal Landscape
3.4.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Pharmaceutical Analytical Testing Outsourcing Market: Segment Analysis, by Service, 2016 - 2027 (USD Million)
4.1. Segment Dashboard
4.2. Definitions & Scope
4.3. Service Market Share Analysis, 2019 & 2027
4.4. Global Pharmaceutical Analytical Testing Outsourcing Market, By Service, 2016 to 2027
4.5. Market Size & Forecasts And Trend Analysis, 2016 to 2027 for the following
4.5.1. Bioanalytical Testing
4.5.1.1. Clinical
4.5.1.2. Non Clinical
4.5.2. Method Development & Validation
4.5.2.1. ExtracTable & Leachable
4.5.2.2. Impurity Method
4.5.2.3. Technical Consulting
4.5.2.4. Others
4.5.3. Stability Testing
4.5.4. Drug Substance
4.5.4.1. Stability Indicating Method Validation
4.5.4.2. Accelerated Stability Testing
4.5.4.3. Photostability Testing
4.5.4.4. Others
4.5.5. Others

Chapter 5. Pharmaceutical Analytical Testing Outsourcing Market: Regional Market Analysis, by Service, 2016 - 2027 (USD Million)
5.1. Regional Market Dashboard
5.2. Regional Market Share Analysis, 2019 & 2027
5.3. Market Size, Forecasts, And Trend Analysis, 2016 to 2027:
5.4. North America
5.4.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
5.4.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.4.3. U.S.
5.4.3.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.4.4. Canada
5.4.4.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5. Europe
5.5.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
5.5.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5.3. U.K.
5.5.3.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5.4. Germany
5.5.4.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5.5. France
5.5.5.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5.6. Italy
5.5.6.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5.7. Spain
5.5.7.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5.8. Russia
5.5.8.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5.9. Turkey
5.5.9.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5.10. Netherlands
5.5.10.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5.11. Switzerland
5.5.11.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.5.12. Sweden
5.5.12.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6. Asia Pacific
5.6.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
5.6.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6.3. China
5.6.3.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6.4. Japan
5.6.4.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6.5. India
5.6.5.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6.6. Australia
5.6.6.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6.7. South Korea
5.6.7.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6.8. Indonesia
5.6.8.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6.9. Malaysia
5.6.9.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6.10. Singapore
5.6.10.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6.11. Thailand
5.6.11.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.6.12. Taiwan
5.6.12.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.7. Latin America
5.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
5.7.2. Brazil
5.7.2.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.7.3. Mexico
5.7.3.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.7.4. Argentina
5.7.4.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.7.5. Colombia
5.7.5.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.7.6. Chile
5.7.6.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.8. Middle East and Africa
5.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
5.8.2. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.8.3. South Africa
5.8.3.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.8.4. Saudi Arabia
5.8.4.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.8.5. UAE
5.8.5.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.8.6. Egypt
5.8.6.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)
5.8.7. Israel
5.8.7.1. Market estimates and forecast, by service, 2016 - 2027 (USD Million)

Chapter 6. Pharmaceutical Analytical Testing Outsourcing Market - Competitive Analysis
6.1. Key companies profiled
6.1.1. SGS SA
6.1.1.1. Company overview
6.1.1.2. Financial performance
6.1.1.3. Product benchmarking
6.1.1.4. Strategic initiatives
6.1.2. Toxikon, Inc.
6.1.2.1. Company overview
6.1.2.2. Financial performance
6.1.2.3. Product benchmarking
6.1.2.4. Strategic initiatives
6.1.3. Eurofins Scientific
6.1.3.1. Company overview
6.1.3.2. Financial performance
6.1.3.3. Product benchmarking
6.1.3.4. Strategic initiatives
6.1.4. Pace Analytical Services, Inc.
6.1.4.1. Company overview
6.1.4.2. Financial performance
6.1.4.3. Product benchmarking
6.1.4.4. Strategic initiatives
6.1.5. Intertek Group Plc
6.1.5.1. Company overview
6.1.5.2. Financial performance
6.1.5.3. Product benchmarking
6.1.5.4. Strategic initiatives
6.1.6. Pharmaceutical Product Development, LLC.
6.1.6.1. Company overview
6.1.6.2. Financial performance
6.1.6.3. Product benchmarking
6.1.6.4. Strategic initiatives
6.1.7. WuXi AppTec, Inc.
6.1.7.1. Company overview
6.1.7.2. Financial performance
6.1.7.3. Product benchmarking
6.1.7.4. Strategic initiatives
6.1.8. Boston Analytical
6.1.8.1. Company overview
6.1.8.2. Financial performance
6.1.8.3. Product benchmarking
6.1.8.4. Strategic initiatives
6.1.9. Boston Analytical
6.1.9.1. Company overview
6.1.9.2. Financial performance
6.1.9.3. Product benchmarking
6.1.9.4. Strategic initiatives
6.1.10. Charles River Laboratories International, Inc.
6.1.10.1. Company overview
6.1.10.2. Financial performance
6.1.10.3. Product benchmarking
6.1.10.4. Strategic initiatives
6.1.11. West Pharmaceutical Services Inc.
6.1.11.1. Company overview
6.1.11.2. Financial performance
6.1.11.3. Product benchmarking
6.1.11.4. Strategic initiatives


*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • SGS SA
  • Toxikon, Inc.
  • Eurofins Scientific
  • Pace Analytical Services, Inc.
  • Intertek Group Plc
  • Pharmaceutical Product Development, LLC.
  • WuXi AppTec, Inc.
  • Boston Analytical
  • Boston Analytical
  • Charles River Laboratories International, Inc.
  • West Pharmaceutical Services Inc.
Note: Product cover images may vary from those shown
Adroll
adroll